Therapy + MIDOMAFETAMINE for stress disorders, post-traumatic

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 3 registered trials.

Why this status

  1. 15 Dec 2010: Trial started, NCT01458327
  2. 24 Oct 2011: Trial registered, NCT01458327

The trials

NCT01458327: Additional MDMA-assisted Therapy for People Who Relapsed After MDMA-assisted Therapy Trial

State
Completed
Phase
Phase 2
People
3 taking part
Started
15 Dec 2010
Primary completion
27 Jun 2014
Arms
MDMA-assisted therapy
Results
Posted on the registry
  1. 15 Dec 2010: Trial started
  2. 24 Oct 2011: Trial registered
  3. 27 Jun 2014: Trial completed
  4. 3 Nov 2021: Trial results posted

NCT04968938: Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD

State
Withdrawn before it started
Phase
Phase 2
People
0 taking part
Started
Aug 2022
Primary completion
Aug 2023
Arms
MDMA-assisted therapy
Results
None posted
  1. 20 Jul 2021: Trial registered
  2. 1 Nov 2024: Trial withdrawn

NCT05173831: Study of Feasibility and Safety of MDMA-Assisted Group Therapy for the Treatment of PTSD in Veterans

State
Withdrawn before it started
Phase
Phase 2
People
0 taking part
Started
Sep 2023
Primary completion
Dec 2024
Arms
Two Sessions of MDMA-assisted therapy
Results
None posted
  1. 30 Dec 2021: Trial registered
  2. 30 Oct 2024: Trial withdrawn

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.